Literature DB >> 1633065

The influence of gastrointestinal transit on drug absorption in healthy volunteers.

S A Riley1, F Sutcliffe, M Kim, M Kapas, M Rowland, L A Turnberg.   

Abstract

1. The effect of variability of gastric emptying and oro-caecal transit on the absorption of a multicomponent solution of frusemide, atenolol, hydrochlorthiazide and salicylic acid has been studied in six healthy subjects. Each subject was studied on five separate occasions: three times under basal conditions, once following metoclopramide and once following codeine pretreatment in an attempt to speed and slow transit respectively. 2. Inter-subject variability of gastric emptying, oro-caecal transit and the rate and extent of drug absorption was considerable. 3. The absorption of salicylic acid appeared rate-limited by gastric emptying but the rate and extent of frusemide, atenolol and hydrochlorthiazide absorption were unrelated to measures of gastric emptying or oro-caecal transit. 4. Codeine phosphate caused a two-fold delay in oro-caecal transit but did not influence gastric emptying while metoclopramide had no significant effect on either function. 5. Metoclopramide and codeine had no significant effect on the rate or extent of absorption of any of the study drugs. 6. Within the limits of this experiment, oro-caecal transit time did not appear to be an important determinant of frusemide, atenolol, hydrochlorothiazide or salicylic acid absorption. Other factors must account for the observed variability in drug absorption.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1633065      PMCID: PMC1381372          DOI: 10.1111/j.1365-2125.1992.tb04104.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  41 in total

1.  Inter- and intrasubject variations of ranitidine pharmacokinetics after oral administration to normal male subjects.

Authors:  C K Shim; J S Hong
Journal:  J Pharm Sci       Date:  1989-12       Impact factor: 3.534

2.  Intra- and intersubject variability: mixed-effects statistical analysis of repeated doses of an angiotensin converting enzyme inhibitor, CGS 16617.

Authors:  G M Kochak; R A Smith; R L Choi; V John; V Tipnis; F Honc; J K deSilva; D J Weidler
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

3.  Transit of pharmaceutical dosage forms through the small intestine.

Authors:  S S Davis; J G Hardy; J W Fara
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

Review 4.  The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation.

Authors:  J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  Effect of codeine and loperamide on upper intestinal transit and absorption in normal subjects and patients with postvagotomy diarrhoea.

Authors:  J D O'Brien; D G Thompson; A McIntyre; W R Burnham; E Walker
Journal:  Gut       Date:  1988-03       Impact factor: 23.059

6.  A comparative study of the pharmacokinetics and pharmacodynamics of atenolol, hydrochlorothiazide and amiloride in normal young and elderly subjects and elderly hypertensive patients.

Authors:  K Sabanathan; C M Castleden; H K Adam; J Ryan; T J Fitzsimons
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Implications of intraindividual variability in bioavailability studies of furosemide.

Authors:  A Grahnén; M Hammarlund; T Lundqvist
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 8.  Clinical pharmacokinetics of the salicylates.

Authors:  C J Needs; P M Brooks
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

9.  Effect of drugs on oro-caecal transit time assessed by the lactulose/breath hydrogen method.

Authors:  D H Staniforth
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Pharmacokinetic and pharmacodynamic interactions between furosemide and hydrochlorothiazide in nephrotic patients.

Authors:  H Nakahama; Y Orita; M Yamazaki; S Itoh; T Okuda; A Yamaji; Y Miwa; M Yanase; Y Fukuhara; T Kamada
Journal:  Nephron       Date:  1988       Impact factor: 2.847

View more
  8 in total

1.  Inter-individual and intra-individual variability of ethanol concentration-time profiles: comparison of ethanol ingestion before or after an evening meal.

Authors:  A G Fraser; S B Rosalki; G D Gamble; R E Pounder
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

2.  Effects of a non-absorbable osmotic load on drug absorption in healthy volunteers.

Authors:  S A Riley; M Kim; F Sutcliffe; M Kapas; M Rowland; L A Turnberg
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

Review 3.  Pharmacokinetic interactions between alcohol and other drugs.

Authors:  A G Fraser
Journal:  Clin Pharmacokinet       Date:  1997-08       Impact factor: 6.447

Review 4.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

Review 5.  Drug interactions with antacids. Mechanisms and clinical significance.

Authors:  D C Sadowski
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

6.  Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology.

Authors:  Christopher T Smith; Jessica Weafer; Ronald L Cowan; Robert M Kessler; Abraham A Palmer; Harriet de Wit; David H Zald
Journal:  J Psychopharmacol       Date:  2016-02-15       Impact factor: 4.153

Review 7.  Effects of surgery on the pharmacokinetic parameters of drugs.

Authors:  J M Kennedy; A M Riji
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447

8.  Pharmacokinetics and pharmacodynamics of oral testosterone enanthate plus dutasteride for 4 weeks in normal men: implications for male hormonal contraception.

Authors:  John K Amory; Thomas F Kalhorn; Stephanie T Page
Journal:  J Androl       Date:  2007-11-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.